116378 ⎘
Hydrolases acting on ester bonds (3.1); Phosphoric diester hydrolases (3.1.4) Phosphoinositide phospholipase C (3.1.4.11)
BIOMARKERS FOR CEREBRAL METABOLIC DISORDERS, AND DIAGNOSTIC METHODS USING THEREOF
#2GENETICALLY MODIFIED MOUSE MODELS OF ALZHEIMER’S DISEASE
#3GTP CYCLOHYDROLASE-CLEAVING PROTEASES
#4PROCESS OF EXTRACTING OIL FROM THIN STILLAGE
#5ENZYMATIC TREATMENT OF FEEDSTOCK FOR HVO PRODUCTION
#6POLYPEPTIDES HAVING PHOSPHOLIPASE C ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME
#7CHIMERIC ANTIGEN RECEPTOR (CAR) SIGNALING MOLECULES FOR CONTROLLED AND SPECIFIC CAR T CELL ACTIVITY
#8EVOLUTION OF BOTULINUM NEUROTOXIN PROTEASES
#9METHOD FOR SYNTHESIZING BETA-NICOTINAMIDE MONONUCLEOTIDE AND INTERMEDIATE THEREOF
#10Process of extracting oil from thin stillage
#11PROCESSES FOR PRODUCING FERMENTATION PRODUCTS
#12PROCESS OF EXTRACTING OIL FROM THIN STILLAGE
#13POLYNUCLEOTIDES FOR DISRUPTING IMMUNE CELL ACTIVITY AND METHODS OF USE THEREOF
#14PESTICIDAL GENES AND METHODS OF USE
#15Process of extracting oil from thin stillage
#16GENETICALLY MODIFIED MOUSE MODELS OF ALZHEIMER'S DISEASE
#17Polypeptides having phospholipase C activity and polynucleotides encoding same
#18Process of extracting oil from thin stillage
#19Culture medium for detection of bacterium belonging to genus
#20PROCESSES FOR PRODUCING FERMENTATION PRODUCTS
#21Process of extracting oil from thin stillage
#22Pesticidal Genes and Methods of Use
#23Polypeptides having phospholipase C activity and polynucleotides encoding same
#24Method of baking
#25PROCESSES FOR PRODUCING FERMENTATION PRODUCTS
#26Processes for producing fermentation products
#27Process of extracting oil from thin stillage
#28USE OF PHOSPHOLIPASE C
#29Polypeptides having phospholipase C activity and polynucleotides encoding same
#30Compositions Comprising Polypeptides Having Phospholipase C Activity and Use Thereof
#31Phospholipases, nucleic acids encoding them and methods for making and using them
#32Pesticidal Genes and Methods of Use
#33Methods and compositions for modulating G-alpha-Q signaling
#34Mutations associated with resistance to inhibitors of Bruton's Tyrosine Kinase (BTK)
#35SPERM FACTOR SEQUENCES
#36Generation of triacylglycerols
#37Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
#38Phospholipases, nucleic acids encoding them and methods for making and using them
#39THERAPEUTIC FORMULATIONS CONTAINING VENOM OR VENOM ANTI-SERUM EITHER ALONE OR IN COMBINATION FOR THE THERAPEUTIC PROPHYLAXIS AND THERAPY OF NEOPLASMS
#40Generation of triacylglycerols from gums
#41Sperm factor sequences
#42THERAPEUTIC FORMULATIONS CONTAINING VENOM OR VENOM ANTI-SERUM EITHER ALONE OR IN COMBINATION FOR THE THERAPEUTIC PROPHYLAXIS AND THERAPY OF NEOPLASMS
#43Treatment of inflammatory conditions